feed,title,long_url,short_url
InsiderMonkey,Analyst Explains Why TJX Companies (TJX) ‘Continues to Win’,https://insidermonkey.com/blog/--1627489,
InsiderMonkey,"Wall Street Bullish on Intuitive Surgical, Inc (ISRG), Ahead of its FQ3 2025 Results",https://insidermonkey.com/blog/--1628205,
InsiderMonkey,"Rothschild & Co. Redburn Downgrades Danaher Corporation (DHR) to Hold, Reduces PT",https://insidermonkey.com/blog/--1628206,
InsiderMonkey,J.P. Morgan Raises PT on Thermo Fisher Scientific (TMO) Keeps an Overweight Rating,https://insidermonkey.com/blog/--1628208,
InsiderMonkey,​Alphabet Inc. (GOOGL) Could Face Stricter Regulations In UK Due to Its Search Dominance,https://insidermonkey.com/blog/--1628209,
InsiderMonkey,China Increases Enforcement of Import Restrictions on Chips from NVIDIA Corporation (NVDA),https://insidermonkey.com/blog/--1628210,
InsiderMonkey,Microsoft Corporation (MSFT) Enters a Licensing Agreement With the Harvard University,https://insidermonkey.com/blog/--1628212,
InsiderMonkey,Amazon.com (AMZN) Plans to Invest 1 Billion Euros in Belgium,https://insidermonkey.com/blog/--1628213,
InsiderMonkey,Alibaba Group Holding Limited (BABA) Announces Multiyear Partnership With NBA China,https://insidermonkey.com/blog/--1628839,
InsiderMonkey,OpenAI to Deploy 6 Gigawatts of Advanced Micro Devices (AMD) GPUs,https://insidermonkey.com/blog/--1628840,
InsiderMonkey,"Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy",https://insidermonkey.com/blog/--1628053,
InsiderMonkey,Mesoblast’s Ryoncil Gains Permanent CMS J-Code for Billing and Reimbursement,https://insidermonkey.com/blog/--1628054,
InsiderMonkey,Northland Doubles Amprius Technologies (AMPX) PT to $20 Following New CFO Appointment,https://insidermonkey.com/blog/--1628055,
InsiderMonkey,JPMorgan Doubles National Energy Services Reunited (NESR) PT to $19 on Strong Growth Potential,https://insidermonkey.com/blog/--1628058,
InsiderMonkey,"Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting",https://insidermonkey.com/blog/--1628060,
InsiderMonkey,"Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene",https://insidermonkey.com/blog/--1628057,
InsiderMonkey,"Guggenheim Initiates Olema Pharmaceuticals (OLMA) Coverage with Buy Rating and $20 PT, Cites Palazestrant Potential",https://insidermonkey.com/blog/--1628061,
